ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
ArriVent BioPharma Inc

ArriVent BioPharma Inc (AVBP)

32.92
-1.41
(-4.11%)
At close: 13 November 8:00AM
32.92
0.00
( 0.00% )
After Hours: 8:10AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
32.92
Bid
31.46
Offer
35.31
Volume
99,612
32.6833 Day's Range 34.35
14.35 52 Week Range 36.37
Market Cap
Previous Close
34.33
Open
34.00
Last Trade Time
08:03:37
Financial Volume
US$ 3,317,249
VWAP
33.3017
Average Volume (3m)
293,235
Shares Outstanding
33,585,893
Dividend Yield
-
PE Ratio
-15.86
Earnings Per Share (EPS)
-2.06
Revenue
-
Net Profit
-69.33M

About ArriVent BioPharma Inc

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therap... ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
ArriVent BioPharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVBP. The last closing price for ArriVent BioPharma was US$34.33. Over the last year, ArriVent BioPharma shares have traded in a share price range of US$ 14.35 to US$ 36.37.

ArriVent BioPharma currently has 33,585,893 shares in issue. The market capitalisation of ArriVent BioPharma is US$1.15 billion. ArriVent BioPharma has a price to earnings ratio (PE ratio) of -15.86.

AVBP Latest News

ArriVent Announces a Multi-Target ADC Collaboration with Alphamab

Collaboration will leverage Alphamab’s antibody drug conjugate (“ADC”) research and discovery platform and ArriVent’s global development and commercialization expertise Upfront and milestone...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.163.652392947131.7636.3731.4317162534.54885221CS
45.1618.587896253627.7636.3727.4213624231.69148644CS
128.7936.427683381724.1336.3722.329323526.38322633CS
2614.9483.092324805317.9836.3715.5317009525.0968326CS
528.9237.16666666672436.3714.3517876122.73583206CS
1568.9237.16666666672436.3714.3517876122.73583206CS
2608.9237.16666666672436.3714.3517876122.73583206CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ONMDOneMedNet Corporation
US$ 1.23
(29.47%)
1.02M
PROCProcaps Group SA
US$ 1.03
(6.19%)
2.6k
PGENPrecigen Inc
US$ 0.997
(5.91%)
3.36k
GRYPGryphon Digital Mining Inc
US$ 0.8715
(5.51%)
10.29k
RNAZTransCode Therapeutics Inc
US$ 0.39
(5.46%)
250
NANano Labs Ltd
US$ 6.74
(-16.06%)
154.13k
NXTTNext Technology Holding Inc
US$ 1.795
(-11.90%)
27.85k
DRCTDirect Digital Holdings Inc
US$ 2.39
(-8.43%)
2.32k
CETYClean Energy Technologies Inc
US$ 0.771
(-8.21%)
4.58k
LSBLakeShore Biopharma Company Ltd
US$ 2.84
(-7.64%)
910
NVDANVIDIA Corporation
US$ 148.31
(-0.06%)
1.21M
TLTiShares 20 plus Year Treasury Bond
US$ 90.78
(0.13%)
1.13M
AAPLApple Inc
US$ 224.23
(0.01%)
1.03M
ONMDOneMedNet Corporation
US$ 1.23
(29.47%)
1.02M
LCIDLucid Group Inc
US$ 2.15
(0.94%)
871.32k

Your Recent History

Delayed Upgrade Clock